Embedded Files
Helping Australian bio-tech companies to develop new medications for psychiatric disorders.
How we can help
How we can help
Below are some of the pressure points for early/mid-stage drug development, which we have expertise in helping with.
Choosing the best preclinical models for lead selection and optimisation
Choosing the best preclinical models for lead selection and optimisation
Evidence-based models which are sensitive to the mechanism of action of your molecules, or to the phenotype you are seeking.
Finding the ideal contract research organisations
Finding the ideal contract research organisations
Matching you with CRO's with the capabilities, reliability, flexibility, dedicated relationships, cost, and experience, suited to your goals and needs.
Planning early for clinical translation
Planning early for clinical translation
Anticipating translation hurdles for your molecules or indication, and optimise early stage development to enable smooth translation to the clinic.
Taking advantage of non-dilutive funding opportunities
Taking advantage of non-dilutive funding opportunities
Strategies to be eligible and competitive for non-dilutive grants, and finding the appropriate academic and institutional partners
Questions?
Questions?
Contact nick@psychopharmacology.com.au to discuss how we can optimise the development and translation of your molecules.
Page updated
Google Sites
Report abuse